Home/Filings/4/0001437749-23-033221
4//SEC Filing

CONKLING WILLIAM 4

Accession 0001437749-23-033221

CIK 0000922247other

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 9:08 AM ET

Size

4.8 KB

Accession

0001437749-23-033221

Insider Transaction Report

Form 4
Period: 2023-11-28
Transactions
  • Award

    Common Stock

    2023-11-28+7,4669,915 total
Footnotes (1)
  • [F1]Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee directorcompensation policy. Grant reflects director compensation for the third quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of $1.34per share of common stock on November 28, 2023.

Issuer

Cyclo Therapeutics, Inc.

CIK 0000922247

Entity typeother

Related Parties

1
  • filerCIK 0001852018

Filing Metadata

Form type
4
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 9:08 AM ET
Size
4.8 KB